deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT01913054

Combined Use of Etomidate and Propofol in Painless Gastroscopy.

Combined Use of Etomidate and Propofol in Painless Gastroscopy, a Multiple Center, Double Blinded, Randomized,Controled Study.

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.

Conditions Safety of Gastroscopy
Interventions Etomidate Fat Emulsion Injection Fentanyl Injection Propofol Injection
Updated 6 times since 2017 Last updated: Dec 13, 2013 Started: Aug 31, 2013 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01913054, this PHASE4 trial focuses on Safety of Gastroscopy and remains ongoing. Sponsored by Jiangsu Nhwa Pharmaceutical Co., Ltd., it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 10 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
Data source: Jiangsu Nhwa Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations